UHealth, University of Miami Miller School of Medicine joined Aclarion’s trial of the Nociscan diagnostic spine tool, according to a June 10 news release.
The Clarity trial is a prospective, randomized clinical study to assess Nociscan’s ability to improve surgical outcomes for chronic lower back pain. Nociscan uses MR spectroscopy and augmented intelligence to identify the source of chronic lower back pain.
“We believe in customizing treatments to each patient’s pathology, goals, needs, and lifestyle, and in this regard, leveraging novel technologies, like Nociscan, to better understand our patient’s low back pain for personalized treatments,” Gregory Basil, MD, director of endoscopic spine at UHealth, said in the release. “The Clarity trial is a unique opportunity for me and my colleagues at the Miller School of Medicine to advance the spine industry and showcase the research capabilities at the University of Miami.”
Several other sites have joined the trial including Chicago-based Northwestern Medicine, Baltimore-based Johns Hopkins Medicine and Plano-based Texas Back Institute.
